SCHEMBL8148529

SCHEMBL8148529

CSc1nc2ccc(Nc3nccc(-c4ccc(N5CCN(C(=O)OCc6ccccc6)CC5)nc4)n3)cc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 3/20 0.45
▸ ZAP70 P43403 5/20 0.43
▸ PIK3CA P42336 2/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ CCNT1 O60563 1/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ CDK9 P50750 1/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ PRKD3 O94806 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ PRKCG P05129 1/20 0.40
▸ PRKCB P05771 1/20 0.40
▸ LCK P06239 1/20 0.40
▸ PRKCA P17252 1/20 0.40
▸ PRKCH P24723 1/20 0.40
▸ PRKCI P41743 1/20 0.40
▸ PRKCE Q02156 1/20 0.40
▸ PRKCQ Q04759 1/20 0.40
▸ PRKCZ Q05513 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8145178 0.84 HDAC1 (0.46) BRAFZAP70HDAC1CCNT1CCNA2
SCHEMBL8146801 0.81 ZAP70 (0.59) ZAP70PRKD3EGFRPRKCGPRKCB
SCHEMBL8139918 0.80 SYK (0.46) BRAFZAP70HDAC1CCNT1CCNA2
SCHEMBL8153192 0.80 BRAF (0.46) BRAFZAP70HDAC1CCNT1CCNA2
SCHEMBL8154797 0.77 ZAP70 (0.53) ZAP70PRKD3EGFRPRKCGPRKCB
SCHEMBL8148183 0.74 HDAC1 (0.53) HDAC1HSD17B10LMNANPSR1ALDH1A1
SCHEMBL8146572 0.73 HDAC1 (0.48) BRAFZAP70HDAC1PRKD3EGFR
SCHEMBL8991383 0.69 NPC1 (0.61) LMNAALDH1A1MAPTNPC1RAB9A
SCHEMBL8148421 0.68 WNT3A (0.49) ZAP70PRKD3EGFRPRKCGPRKCB
SCHEMBL8148560 0.68 ZAP70 (0.48) BRAFZAP70CCNT1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6093716-A Substituted 2-pyrimidineamines and processes for their preparation CELLTECH THERAPEUTICS, LIMITED (GB) 2000-07-25 — — US disclosed
EP-0929549-A1 SUBSTITUTED 2-PYRIMIDINEAMINES, THEIR PREPARATION AND THEIR USE AS PROTEINE KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1999-07-21 — — EP disclosed
WO-1998011095-A1 SUBSTITUTED 2-PYRIMIDINEAMINES, THEIR PREPARATION AND THEIR USE AS PROTEINE KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-03-19 — — WO disclosed
Send feedback